Evidence map›Paper›PMID 39092222›Full record

ArticleFrontiers in pharmacology2024

Artemvulactone E isolated from

Zibo Zhao, Shimin Lin, Tao Liu, Xiao Hu, Shurong Qin, Fengyun Zhan, Jiaqi Ma, Chen Huang, Zhibin Huang, Yifei Wang and 3 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zibo Zhao *Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Shimin Lin *Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Tao Liu *Guangdong Province Key Laboratory of Bioengineering Medicine, Jinan University, Guangzhou, China.
Xiao HuGuangdong Provincial Biotechnology Drug and Engineering Technology Research Center, Jinan University, Guangzhou, China.
Shurong QinNational Engineering Research Center of Genetic Medicine, Jinan University, Guangzhou, China.
Fengyun ZhanDepartment of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Jiaqi MaKey Laboratory of Innovative Technology Research on Natural Products and Cosmetics Raw Materials, Jinan University, Guangzhou, China.
Chen HuangKey Laboratory of Innovative Technology Research on Natural Products and Cosmetics Raw Materials, Jinan University, Guangzhou, China.
Zhibin HuangDivision of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou, China.
Yifei WangNational Engineering Technology Research Center for Modernization of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Kai ZhengSchool of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, China.
Wenqing ZhangDivision of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou, China.
Zhe RenDepartment of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Natural plants are valuable resources for exploring new bioactive compounds. Methods: The immunoregulatory effects of AE on macrophages were assessed by ELISA, RT-qPCR, immunofluorescence, and western blot assay. The effect of AE on lipopolysaccharide (LPS) -relates signaling pathways was examined by western blot assay. In zebrafish models, the larvae were yolk-microinjected with LPS to establish inflammation model and the effect of AE was evaluated by determining the survival rate, heart rate, yolk sac edema size, neutrophils and macrophages infiltration of zebrafish. The interaction between AE and Toll-like receptor 4 (TLR4) was examined by molecular docking and dynamic stimulation. Results: AE reduced the expression and secretion of pro-inflammatory cytokines (TNF-α and IL-6), inflammatory mediators iNOS and COX-2, as well as decreases the production of intracellular NO and ROS in LPS-stimulated macrophages. In addition, AE exerted its anti-inflammatory effect synergistically by inhibiting MAPK/JAK/STAT3-NF-κB signaling pathways. Furthermore, AE enhanced the survival rate and attenuated inflammatory response in zebrafish embryos treated with LPS. Finally, the molecular dynamics results indicate that AE forms stable complexes with LPS receptor TLR4 through the Ser127 residue, thus completely impairing the subsequent activation of MAPK-NF-κB signaling. Conclusion: AE exhibits notable anti-inflammatory activity and represents as a potential agent for treating inflammation-associated diseases.

Indexed as

artemvulactone Einflammationmolecular dynamicsTLR4zebrafish

Identifiers

PMID39092222
PMCPMC11291208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.